The solution uses the Company’s AI-driven Therapy Initiation and Persistence Platform to deliver tailored engagement leveraging real-world evidence insights in real-time
OptimizeRx Corp., a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced its Evidence-based Physician Engagement solution has been recognized as one of the most innovative products of the year for life sciences by PM360.
Read More: SalesTechStar Interview with Damon Miño, VP of Sales at Ironclad
OptimizeRx’s Evidence-Based Physician Engagement solution uses the Company’s AI-driven Therapy Initiation and Persistence Platform to deliver insights in real time. Using predictive analytics via machine learning methods, the platform can assist healthcare providers (HCPs) in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. This application of real-world evidence (RWE) in practice translates to better support for providers as they look to make the best treatment decisions for their patients, especially for those with complex dosing requirements or chronic disease indications.
Steve Silvestro, OptimizeRx’s chief commercial officer said, “We launched our evidence-based engagement solution with a ‘patient first’ focus to help manufacturers identify which HCPs to engage by first identifying if they have patients in need of support, based on where they are in their care journey and disease state. This approach helps reduce delay in support delivery and can make a compelling difference in patients’ lives. We continue to see growing interest from pharma manufacturers, and we have already successfully onboarded several enterprise clients this year. This early success demonstrates the need for technologies that improve patient treatment outcomes through a real-time approach to leveraging RWE at the point of care. With the ongoing uncertainties caused by COVID-19 and its variants, we see continued demand for this solution growing over time as adoption increases, especially for specialty medications with complex dosing requirements.”
Read More: SalesTechStar Interview with Jeremey Donovan, Head of Revenue Strategy at Salesloft
PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, publishes its Innovation issue each December. Its 10th annual Innovation Issue serves as a guide to the year’s most innovative companies, startups, divisions, products, services, and strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.
“Out of necessity, 2021 was one of the most innovative years for our industry, so to be among the selections for this year’s Innovations Issue truly speaks volumes to what these companies, offerings, and strategies have been able to accomplish,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “In the midst of a crisis, our industry’s brightest minds found ways to solve issues caused by the pandemic, improve upon ways healthcare and pharma operates, and envision a better future where we are able to be more agile, accommodating, and prepared for whatever comes next.”
